Hong T - Search Results

1

Anti-VEGF Therapy for Diabetic Eye Diseases.

Bahrami B, Hong T, Gilles MC, Chang A. Bahrami B, et al. Among authors: hong t. Asia Pac J Ophthalmol (Phila). 2017 Nov-Dec;6(6):535-545. doi: 10.22608/APO.2017350. Epub 2017 Oct 26. Asia Pac J Ophthalmol (Phila). 2017. PMID: 29076303 Free article. Review.

2

Development and progression of diabetic retinopathy 12 months after phacoemulsification cataract surgery.

Hong T, Mitchell P, de Loryn T, Rochtchina E, Cugati S, Wang JJ. Hong T, et al. Ophthalmology. 2009 Aug;116(8):1510-4. doi: 10.1016/j.ophtha.2009.03.003. Epub 2009 Jun 5. Ophthalmology. 2009. PMID: 19501407

3

Long-term changes in visual acuity in an older population over a 15-year period: the Blue Mountains Eye Study.

Hong T, Mitchell P, Rochtchina E, Fong CS, Chia EM, Wang JJ. Hong T, et al. Ophthalmology. 2013 Oct;120(10):2091-9. doi: 10.1016/j.ophtha.2013.03.032. Epub 2013 May 30. Ophthalmology. 2013. PMID: 23726666

4

Intravitreal aflibercept for treatment-resistant neovascular age-related macular degeneration.

Chang AA, Li H, Broadhead GK, Hong T, Schlub TE, Wijeyakumar W, Zhu M. Chang AA, et al. Among authors: hong t. Ophthalmology. 2014 Jan;121(1):188-192. doi: 10.1016/j.ophtha.2013.08.035. Epub 2013 Oct 18. Ophthalmology. 2014. PMID: 24144450 Clinical Trial.

5

Treating the untreatable patient: current options for the management of treatment-resistant neovascular age-related macular degeneration.

Broadhead GK, Hong T, Chang AA. Broadhead GK, et al. Among authors: hong t. Acta Ophthalmol. 2014 Dec;92(8):713-23. doi: 10.1111/aos.12463. Epub 2014 Jun 12. Acta Ophthalmol. 2014. PMID: 24925048 Free article. Review.

6

Intravitreal Ranibizumab for neovascular Age-related macular degeneration in clinical practice: five-year treatment outcomes.

Zhu M, Chew JK, Broadhead GK, Luo K, Joachim N, Hong T, Syed A, Chang AA. Zhu M, et al. Among authors: hong t. Graefes Arch Clin Exp Ophthalmol. 2015 Aug;253(8):1217-25. doi: 10.1007/s00417-014-2799-8. Epub 2014 Sep 10. Graefes Arch Clin Exp Ophthalmol. 2015. PMID: 25205618

7

Response of pigment epithelial detachments to intravitreal aflibercept among patients with treatment-resistant neovascular age-related macular degeneration.

Broadhead GK, Hong T, Zhu M, Li H, Schlub TE, Wijeyakumar W, Chang AA. Broadhead GK, et al. Among authors: hong t. Retina. 2015 May;35(5):975-81. doi: 10.1097/IAE.0000000000000409. Retina. 2015. PMID: 25627086

8

AUTHORS' REPLY to the Letter to the Editor Regarding "Patients' Short-term Satisfaction With Cataract Surgery and Long-term Sustainability of Improved Visual-Related Quality of Life Over 3 Postoperative Years".

Wang JJ, Hong T, Mitchell P. Wang JJ, et al. Among authors: hong t. Asia Pac J Ophthalmol (Phila). 2014 Jul-Aug;3(4):260. doi: 10.1097/APO.0000000000000074. Asia Pac J Ophthalmol (Phila). 2014. PMID: 26107768 Free article. No abstract available.

9

The role of aflibercept in the management of diabetic macular edema.

Chang AA, Hong T, Ewe SY, Bahrami B, Broadhead GK. Chang AA, et al. Among authors: hong t. Drug Des Devel Ther. 2015 Aug 6;9:4389-96. doi: 10.2147/DDDT.S62778. eCollection 2015. Drug Des Devel Ther. 2015. PMID: 26273198 Free PMC article. Review.

10

Intravitreal Aflibercept for Treatment-Resistant Neovascular Age-Related Macular Degeneration: 12-Month Safety and Efficacy Outcomes.

Chang AA, Broadhead GK, Hong T, Joachim N, Syed A, Schlub TE, Toth L, Peto T, Zhu M. Chang AA, et al. Among authors: hong t. Ophthalmic Res. 2015;55(2):84-90. doi: 10.1159/000440886. Epub 2015 Dec 5. Ophthalmic Res. 2015. PMID: 26637166 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,350 results

Search Page

Filters